100 related articles for article (PubMed ID: 2318281)
1. Effect of gemfibrozil on erythrocyte membrane lipids in geriatric patients.
Bauer M; Platt D; Hager K
Exp Gerontol; 1990; 25(1):37-46. PubMed ID: 2318281
[TBL] [Abstract][Full Text] [Related]
2. Serum and erythrocyte membrane phospholipids fatty acid composition in hyperlipidemia: effects of dietary intervention and combined diet and fibrate therapy.
Ristic-Medic D; Suzic S; Vucic V; Takic M; Tepsic J; Glibetic M
Gen Physiol Biophys; 2009; 28 Spec No():190-9. PubMed ID: 19893100
[TBL] [Abstract][Full Text] [Related]
3. Gemfibrozil lowers plasma lipids and increases polyunsaturated fatty acid content and oxidative susceptibility of lipoproteins in hypertriglyceridemia.
Smith WG; Wang J; Dang AQ; Reeves C; Bibbs D; Faas FH
Clin Chim Acta; 2002 Aug; 322(1-2):77-84. PubMed ID: 12104084
[TBL] [Abstract][Full Text] [Related]
4. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
5. Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources.
Ruíz-Gutiérrez V; Muriana FJ; Guerrero A; Cert AM; Villar J
J Hypertens; 1996 Dec; 14(12):1483-90. PubMed ID: 8986934
[TBL] [Abstract][Full Text] [Related]
6. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
Aguilar-Salinas CA; Fanghänel-Salmón G; Meza E; Montes J; Gulías-Herrero A; Sánchez L; Monterrubio-Flores EA; González-Valdez H; Gómez Pérez FJ
Metabolism; 2001 Jun; 50(6):729-33. PubMed ID: 11398153
[TBL] [Abstract][Full Text] [Related]
7. Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study.
Vahlquist C; Olsson AG; Lindholm A; Vahlquist A
Acta Derm Venereol; 1995 Sep; 75(5):377-80. PubMed ID: 8615057
[TBL] [Abstract][Full Text] [Related]
8. [The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia].
Jian J; Hao X; Deng C; Zhou H; Lin J
Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):517-9. PubMed ID: 11798687
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical modifications induced by statins therapy on human erythrocytes membranes.
Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550
[TBL] [Abstract][Full Text] [Related]
10. [Gemfibrozil in the elderly. Effects on lipid metabolism].
Brosche T; Kipfmüller G
Fortschr Med; 1996 May; 114(13):157-60. PubMed ID: 8964557
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study.
Jen SL; Chen JW; Lee WL; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):217-24. PubMed ID: 9216117
[TBL] [Abstract][Full Text] [Related]
12. [Gemfibrozil in the treatment of hyperlipidemia].
Wang JJ; Song YM; Wang YS; Lin WH
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):131-4. PubMed ID: 2766068
[TBL] [Abstract][Full Text] [Related]
13. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
14. Effect of gemfibrozil on fatty acids in lipid fractions of plasma from patients with hypertriglyceridemia.
Tavella M; Corder CN; McConathy W
J Clin Pharmacol; 1993 Jan; 33(1):35-9. PubMed ID: 8429111
[TBL] [Abstract][Full Text] [Related]
15. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
Mazzella G; Bazzoli F; Villanova N; Simoni P; Festi D; Roda A; Aldini R; Roda E
Scand J Gastroenterol; 1990 Dec; 25(12):1227-34. PubMed ID: 2274744
[TBL] [Abstract][Full Text] [Related]
16. [Gemfibrozil in the treatment of lipid metabolism disorders].
Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321
[TBL] [Abstract][Full Text] [Related]
17. Effect of gemfibrozil on serum lipids in man.
Fenderson RW; Deutsch S; Menachemi E; Chin B; Samuel P
Angiology; 1982 Sep; 33(9):581-93. PubMed ID: 6751166
[TBL] [Abstract][Full Text] [Related]
18. Effect of gemfibrozil on serum levels of prostacyclin and precursor fatty acids in hyperlipidemic patients with Type 2 diabetes.
Yoshinari M; Asano T; Kaori S; Shi AH; Wakisaka M; Iwase M; Fujishima M
Diabetes Res Clin Pract; 1998 Dec; 42(3):149-54. PubMed ID: 9925344
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders.
Murdock DK; Murdock AK; Murdock RW; Olson KJ; Frane AM; Kersten ME; Joyce DM; Gantner SE
Am Heart J; 1999 Jul; 138(1 Pt 1):151-5. PubMed ID: 10385779
[TBL] [Abstract][Full Text] [Related]
20. Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia.
Yang CY; Gu ZW; Xie YH; Valentinova NV; Yang M; Yeshurun D; Quion JA; Gotto AM
Atherosclerosis; 1996 Sep; 126(1):105-16. PubMed ID: 8879439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
